Evidence map›Paper›PMID 32387041›Full record

ArticleArchives of medical research2020

COVID-19 and Moral Imperialism in Multinational Clinical Research.

Fernando Hellmann, Bryn Williams-Jones, Volnei Garrafa

Abstract read
In one paragraph

Article in Archives of medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fernando HellmannDepartment of Public Health, Federal University of Santa Catarina, Campus Universitário Reitor João David Ferreira Lima, Santa Catarina, Brazil. Electronic address: fernando.hellmann@ufsc.br.
Bryn Williams-JonesBioethics Program, Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Quebec, Canada.
Volnei GarrafaUNESCO Chair and Post Graduate Program in Bioethics, University of Brasilia, Brasilia, DF, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A TV debate in April 2020 between two French doctors regarding the benefits of testing a coronavirus vaccine in Africa where there are no masks or treatments available has led to international criticism. This case highlights a problematic ethical double standard in multinational clinical research: trials that would be considered unethical in high income countries (e.g., placebo-controlled where there is an existing treatment) are nonetheless justified in low-and-middle-income countries because the existing standards of care are less (i.e., no access to a treatment). Underlying this ethical double standard in some multinational clinical trials is a moral imperialism and persistent colonialist thinking that must be rejected.

Indexed as

Ethics, ResearchAfricaBetacoronavirusClinical Trials as TopicColonialismCoronavirus InfectionsCOVID-19COVID-19 VaccinesDeveloping CountriesEthical RelativismFranceHuman ExperimentationHumansMoral ObligationsPandemicsPersonal Protective EquipmentCOVID-19 VaccinesViral VaccinesClinical trialsColonialismCOVID-19EthicsLow-and-middle-income countriesResearch design

Identifiers

PMID32387041
PMCPMC7188637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.